Literature DB >> 15706352

Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.

T Hershko1, M Chaussepied, M Oren, D Ginsberg.   

Abstract

The E2F1 transcription factor is a critical downstream target of the tumor suppressor RB. When activated, E2F1 induces cell proliferation. In addition, E2F1 can induce apoptosis via both p53-dependent and p53-independent pathways. A number of E2F-regulated genes, including ARF, ATM and Chk2, contribute to E2F-induced p53 stabilization. However, it is not known how E2F directs p53 activity towards apoptosis rather than growth arrest. We show that E2F1 upregulates the expression of four proapoptotic cofactors of p53--ASPP1, ASPP2, JMY and TP53INP1--through a direct transcriptional mechanism. Adenovirus E1A protein also induces upregulation of these genes, implicating endogenous E2F in this effect. TP53INP1 was shown to mediate phosphorylation of p53 on serine 46. We demonstrate that activation of E2F1 leads to phosphorylation of p53 on serine 46 and this modification is important for E2F1-p53 cooperation in apoptosis. Overall, these data provide novel functional links between RB/E2F pathway and p53-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15706352     DOI: 10.1038/sj.cdd.4401575

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  35 in total

1.  An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence.

Authors:  Arnaud M Vigneron; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

2.  The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemias.

Authors:  Kensuke Kojima; Jared K Burks; Janine Arts; Michael Andreeff
Journal:  Mol Cancer Ther       Date:  2010-08-24       Impact factor: 6.261

3.  Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

Review 4.  Life and death decisions by the E2F transcription factors.

Authors:  Phillip J Iaquinta; Jacqueline A Lees
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

5.  Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals.

Authors:  Xinyu Tian; Bo Huang; Xiao-Peng Zhang; Mingyang Lu; Feng Liu; José N Onuchic; Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

6.  Oxidative stress-induced p53 activity is enhanced by a redox-sensitive TP53INP1 SUMOylation.

Authors:  S Peuget; T Bonacci; P Soubeyran; J Iovanna; N J Dusetti
Journal:  Cell Death Differ       Date:  2014-03-07       Impact factor: 15.828

7.  Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.

Authors:  Durgadevi Ravillah; Altaf Mohammed; Li Qian; Misty Brewer; Yuting Zhang; Laura Biddick; Vernon E Steele; Chinthalapally V Rao
Journal:  J Pharmacol Exp Ther       Date:  2013-11-11       Impact factor: 4.030

Review 8.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  The TP53INP2 protein is required for autophagy in mammalian cells.

Authors:  Jonathan Nowak; Cendrine Archange; Joël Tardivel-Lacombe; Pierre Pontarotti; Marie-Josèphe Pébusque; Maria Inés Vaccaro; Guillermo Velasco; Jean-Charles Dagorn; Juan Lucio Iovanna
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

10.  Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.

Authors:  M T de Bruijn; D A E Raats; F J H Hoogwater; W J van Houdt; K Cameron; J P Medema; I H M Borel Rinkes; O Kranenburg
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.